Back to all studies
🎗️
Phase 2
Oncology
in-person
Circulating Tumor DNA
Sponsored by Yale University
Compensation
$500–$2,500
Duration
3 months
Location
Multi-State
About this study
This is a single-arm, phase II study examining elacestrant in the adjuvant treatment of patients with ER+ breast cancer who test positive for circulating tumor DNA (ctDNA) during the screening period of the trial. Our trial will proceed in three separate phases: screening, treatment, and follow-up.
Who can participate
- • Adults aged 18–99
- • All genders welcome
- • Diagnosed with or experiencing er+ breast cancer
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.